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An infectious disease that is transmitted from animals to humans, sometimes by a vector,
is called zoonosis. The focus of this review article is on the most common emerging and
re-emerging bacterial zoonotic diseases. The role of “One Health” approach, public health
education, and some measures that can be taken to prevent zoonotic bacterial infections
are discussed.
Key points:
• A zoonotic bacterial disease is a disease that can be very commonly transmitted between
animals and humans. Global climate changes, overuse of antimicrobials in medicine,
more intensified farm settings, and closer interactions with animals facilitate emergence
or re-emergence of bacterial zoonotic infections.
• The global “One Health” approach, which requires interdisciplinary collaborations and
communications in all aspects of health care for humans, animals, and the environment,
will support public health in general.
• New strategies for continuous dissemination of multidisciplinary research findings
related to zoonotic bacterial diseases are hence needed.
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INTRODUCTION
Zoonotic diseases are those infections that can be transmitted
between animals and humans with or without vectors. There
are approximately 1500 pathogens, which are known to infect
humans and 61% of these cause zoonotic diseases (1). The unique
dynamic interaction between the humans, animals, and pathogens,
sharing the same environment should be considered within the
“One Health” approach, which dates back to ancient times of
Hippocrates (2, 3).
Bacterial zoonotic diseases can be transferred from animals to
humans in many ways (4): (i) The transfer may occur through ani-
mal bites and scratches (5); (ii) zoonotic bacteria originating from
food animals can reach people through direct fecal oral route,
contaminated animal food products, improper food handling,
and inadequate cooking (6–8); (iii) farmers and animal health
workers (i.e., veterinarians) are at increased risk of exposure to
certain zoonotic pathogens and they may catch zoonotic bacte-
ria; they could also become carriers of the zoonotic bacteria that
can be spread to other humans in the community (9); (iv) vec-
tors, frequently arthropods, such as mosquitoes, ticks, fleas, and
lice can actively or passively transmit bacterial zoonotic diseases
to humans. (10); (v) soil and water recourses, which are contam-
inated with manure contains a great variety of zoonotic bacteria,
creating a great risk for zoonotic bugs and immense pool of resis-
tance genes that are available for transfer of bacteria that cause
human diseases (11, 12).
Bacterial zoonotic infections are one of the zoonotic diseases,
which can, in particular, re-emerge after they are considered to
be eradicated or under control. The development of antimicro-
bial resistance due to over-/misuse of antibiotics is also a globally
increasing public health problem. These diseases have a negative
impact on travel, commerce, and economies worldwide. In most
industrialized countries, antibiotic resistant zoonotic bacterial dis-
eases are of particular importance for at-risk groups such as young,
old, pregnant, and immune-compromised individuals (13).
Almost 100 years ago, prior to application of hygiene rules
and discovery of neither vaccines nor antibiotics, some bacterial
zoonotic diseases such as bovine tuberculosis, bubonic plague, and
glanders caused millions of human deaths. The spread and impor-
tance of some bacterial zoonoses are currently globally increasing.
That is precisely why most of the developing countries are spar-
ing more resources for a better screening of animal products and
bacterial reservoirs or vectors for an optimal preventative public
health service (14).
Improvements in surveillance and diagnostics have caused
increased recognition of emerging zoonotic diseases. Herein,
changes in our lifestyles and closer contacts with animals have
escalated or caused the re-emergence of some bacterial infections.
Some studies lately have revealed that people have never been
exposed to bacterial zoonotic infection risks as high as this before
(15). It is probably due to closer contact with adopted small ani-
mals, which are accepted and treated as a family member in houses.
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On the other hand, more intensified animal farms, which have a
crucial role in the food supply, are still one of the greatest sources of
food-borne bacterial zoonotic pathogens in today’s growing world
(4, 8).
People who have closer contact with large numbers of ani-
mals such as farmers, abattoir workers, zoo/pet-shop workers, and
veterinarians are at a higher risk of contracting a zoonotic dis-
ease. Members of the wider community are also at risk from those
zoonoses that can be transmitted by family pets.
The immune-suppressed people are especially at high risk for
infection with zoonotic bacterial diseases. People can be either
temporarily immuno-suppressed owing to pregnancy, infant age,
or long-term immuno-suppressed as a result of cancer treatment
or organ transplant, diabetes, alcoholism or an infectious disease
(i.e., AIDS).
This manuscript reviews the most common bacterial zoonoses
and practical control measures against them.
COMPANION ANIMAL-BORNE ZOONOSES
Companion animals are increasingly treated as family mem-
bers, and pets have many bacteria that may infect their own-
ers. The human population of the European Union (EU) was
approximately 500 million1 in 2012. The number of pet owning
households was estimated at around 70 million in 20102.
The most commonly suffered zoonotic bacterial infections in
humans are transmitted via animal bites and scratches. Various
dog breeds have been characterized for their role in killing dog
bite attacks, such as pit bull breeds, malamutes, chows, rottweiler,
huskies, German shepherds, and wolf hybrids (16–18). In USA,
pit bull breeds accounted for almost half of the dog bite-related
zoonotic infections, three times more than German shepherds
(17). The oral cavity of healthy dogs and cats contains hundreds of
different pathogenic bacteria including Pasteurella sp. (19). Only
20% of dog bites get infected overall compared with 60% in cats.
There are 10 times higher Pasteurella multocida infection risks after
a cat bite than a dog bite (20, 21). P. multocida infected bite wounds
appear usually within 8 h.
It is estimated that approximately 20% of animal bites or
scratches get infected in humans (5). Bacterial culturing from
pet bite infections in humans is found to be smilar to the oral
microbiota of the pets. Infections in dog bite wounds are usually
dominated by aerobic bugs: P. multocida (50%), alpha-hemolytic
Streptococcus (46%), Staphylococcus (46%), Neisseria (32%), and
Corynebacterium (12%). However, following anaerobic bacteria
are also isolated from infected wounds: Fusobacterium nuclea-
tum (16%), Prevotella heparinolytica (14%), Propionibacterium
acnes (14%), Prevotella intermedia (8%), and Peptostreptococcus
anaerobius (8%) (22).
Normal human skin bacteria or other environmental microor-
ganisms are scarcely isolated from infected wounds in bitten
person (22–24). Usually, infection occurs within 8–24 h after the
animal attack, with variable pain on the site of the injury. The cel-
lulitis might be followed by discharge that contains pus, which
can sometimes be foul-smelling. Immuno-suppressed patients
1http://epp.eurostat.ec.europa.eu/
2http://www.fediaf.org/facts-figures/
with diabetes or liver dysfunction are frequently predisposed to
develop serious infections after animal bites. In those cases, they
may develop bacteremia faster and pass away in a shorter period
of time (5). A penetrating bite close to the joints and bones may
cause septic arthritis and osteomyelitis. Knowing the microbial
composition of dental plaque biofilm formation in pets’ mouth is
a key factor in wound chronicity in humans (5, 25).
Cat-scratch disease is a clinical syndrome that has been reported
in people for over 100 years. Yet, the etiological agent Bartonella
henselae, which was transmitted by cat scratches and bites, was only
identified in 1992 (26). However, contact with cat saliva on broken
skin or sclera can also cause Bartonellosis. A person who has had
a cat scratch may show papules and pustules at the site of injury
(the first initial sign). The disease may progress with a chronic
non-healing wound, fever (sometimes), weak regional lymph cir-
culation, and abscession. Cat owners and veterinarians are most at
risk (27). Systematic medical treatment is usually needed in peo-
ple with suppressed immune systems. Otherwise, encephalopathy,
osteomyelitis, and granulomatous conjunctivitis might develop.
Horses and humans have always shared a close relationship
due to recreation, sporting, and occupational reasons, for over
thousands of years. In Europe, the number of horses per capita
remained relatively stable during the past decade. Germany and
Great Britain have the largest horse populations in the EU, whereas
Sweden has the highest number of horses per capita. The frequency
of infected horse bite wounds is estimated to be 3–5% in Europe
(28,29). However, it has been roughly estimated that the horse bites
account for as high as 20% of overall animal bites in Turkey, which
comes after dog bites (70%) (30). More extensive muscle damage
may develop in most of the horse attacks, which is different from
small animal bites. A mixture of aerobic and anaerobic organisms
has been isolated from horse bites in humans, which are frequently
dominated by Actinobacillus lignieresii (31, 32). Escherichia coli
and Bacteroides species have also been isolated from foul-smelling
infections and pus drainage after horse bites in humans (33).
Infectious diarrhea in companion animals is caused by Sal-
monella sp., Escherichia coli, Shigella sp., and Campylobacter sp. can
also be transmitted to people through fecal oral route. It is difficult
to estimate the distribution of these ubiquitous microorganisms.
But it is known that they can be isolated from many healthy ani-
mals, which can be shed in their feces for long periods of time.
Campylobacteriosis were the most frequently reported zoonotic
bacterial diseases in 2009 among the EU member countries in
humans (34). Like many other enteropathogens, they can cause
gastroenteritis (diarrhea, vomiting), headaches, and depression,
sometimes even leading to death. It is obvious that raw food diets
for pets dramatically increase the risk of human exposure to such
zoonotic bacterial enteropathogens, which cause gastrointestinal
diseases.
Although pet birds, also called songbirds (e.g., canaries, finches,
sparrows) and psittaciformes (e.g., parrots, parakeets, budgerigars,
love birds) are a small fraction of adopted pets, they are widely pop-
ular in Europe and they are potential carriers of zoonotic diseases
(35). Some of them could have an important impact on human
health, such as chlamydophilosis (36), campylobacteriosis (37),
and salmonellosis (38). Parrot fever (chlamydophilosis), which is
caused by intracellular bacteria, Chlamydia psittaci, lives within the
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respiratory system of birds. Inhalation of dust, dander, and nasal
secretions of infected birds is the main way of transmission to
humans (39, 40). The mild to severe flu-like illnesses may develop
and infected people might be misdiagnosed as influenza.
There is unfortunately a lack of quantitative research into
the antimicrobial susceptibility of bacterial zoonotic organisms
isolated from bite/scratch wounds or companion animal asso-
ciated gastroenteritis. Zambori et al. (5) revealed an increased
prevalence of drug resistance in animal bite isolates from people.
Furthermore, methicillin-resistant Staphylococcus aureus (MRSA)
or extended-spectrum beta-lactamases (ESBL) producing Enter-
obacteriaceae, which are known as nosocomial infections have
been frequently isolated in companion animals (41), including
horses (42). It might be one of the main reasons for the rising
prevalence of these potential zoonotic pathogens in human clinical
samples.
FARM ANIMAL-BORNE BACTERIAL ZOONOSES
Food producing animals in stock has reached a total of more than
200 million (cattle, pigs, sheep, goats, and chicken) living on farms
in Europe (see text footnote 1). It has been demonstrated that farm
animals are reservoirs of many zoonotic pathogens to humans (34,
43). However, annually, a large amount of drugs are being used
worldwide to sufficient quantities of food to feed a rapidly grow-
ing world human population (44–47). The farm animals consume
worldwide approximately eight million kilograms of antibiotics
annually (70% of which is used for non-therapeutic purposes such
as growth promotion; forbidden in the EU from January 2006, and
disease prevention) compared with only approximately one mil-
lion kilogram per year used in human medicine (7). Antibiotics are
routinely fed to livestock as growth promoters to increase profits
and to ward off potential bacterial infections in the stressed and
crowded livestock factory environment (48–52).
Despite large differences in methodology, most results demon-
strate that not so long after the introduction of an antibiotic
in veterinary practice, resistance in pathogenic zoonotic bacte-
ria and/or the fecal flora increases. In particular, the wide-spread
use of antibiotics in animals has resulted in an increased emer-
gence of bacterial resistance to antibiotics, in zoonotic organisms
such as Salmonella, Campylobacter, Shigella, Yersinia, Listeria, and
Enterococcus genera, as well as the E. coli species. These zoonotic
bacterial organisms are propagated primarily among animals and
subsequently infect people (53–56). Humans can be infected by
contact with animals and their dung or droppings or consump-
tion of infected food. Severe diarrhea may develop, sometimes
with blood in the feces. At all ages, but especially in children under
5 years and adults over 65 years, very serious illnesses often occur.
These complications can result in loss of life or permanent kidney
damage. According to the latest epidemiological trends, Salmonel-
losis and Campylobacteriosis are indicated as the most frequent
food-borne bacterial zoonoses in Europe. The main food sources
were eggs and mixed foods (57).
Furthermore, the recent emergence of ESBL-producing and
carbapenemase positive Enterobacteriaceae bacteria in animal
production (58), the emergence of farm associated MRSA ST398
(the main pig associated clone) (59–61), and of plasmid-mediated
quinolone resistance in animal isolates and food products (62, 63)
are great threat for public health. Unfortunately, these antimicro-
bial resistant “superbugs” are not only confined to hospital envi-
ronments where antimicrobial use was high and many pathogens
were prevalent. They are already widespread in the European com-
munity and animal populations that have a great hazard on public
health (64, 65).
The causative agent of bovine tuberculosis, Mycobacterium
bovis (M. bovis) has been identified worldwide. Thanks to decades
of disease control measures that the occurrence of the infection
has been greatly reduced. But there are still hundreds of new cases
of human tuberculosis reported in the USA (66). Experience in
Europe and the USA, has shown that M. bovis can be controlled
when it is restricted in livestock; however, eradication is almost
impossible once it has spread into wildlife as follows; the Euro-
pean badger in the United Kingdom (67), elk in Canada (68) and
white tailed deer in the USA (69).
In the last decade, Q fever caused by Coxiella burnetii was one
of the most devastating farm animal originated bacterial zoonotic
bacteria in Europe. The Netherlands, in particular, has experienced
several outbreaks from 2007 to 2010 following identification of a
Q fever outbreak on various dairy farms in 2007. Infected humans
were mainly located within the intensive dairy goat farms (<5 km)
(70). The infection is spread by ticks, inhalation of the organism
from the placental fluids, urine, and consumption of unpasteur-
ized milk – meat products of sheep, goats, and cattle. The clinical
signs in humans might be severe flu-like syndrome that may last
for months (71).
VECTOR-BORNE BACTERIAL ZOONOSES
In the EU, many vector-borne zoonotic diseases are considered as
emerging infectious diseases, which either appear in a population
for the first time or may have existed previously but spreading
rapidly. The ecology of vector-borne zoonotic bacterial diseases is
complex where climate and weather may influence the transmis-
sion cycles. Milder winters, earlier start of spring or long intervals
between winters cause extended seasonal tick activity and hence
pathogen transmission between hosts in new regions of the world
(72, 73). Many vector-borne infections occurred in new regions in
the past two decades, while many endemic diseases have increased
in incidence (74).
The following bacterial pathogens were most frequently iden-
tified as the causes of emerging vector-borne infections in the
last decades in the EU: Rickettsiae spp., Anaplasma phagocy-
tophilum, Borrelia burgdorferi, Bartonella spp., and Francisella
tularensis (75, 76).
Rickettsia rickettsii causes Rocky Mountain spotted fever and
spreads to humans by ticks. The signs of this disease are fever,
headache, muscle pain, and spots with very dark rash. Hiking
in an area with many infested ticks is a great risk factor. A tick
bite of <20 h is usually not enough to transfer these bacteria to a
person (77).
Ehrlichiosis (Anaplasma phagocytophilum) and Lyme disease
(Borrelia burgdorferi) have emerged as an important vector-borne
zoonotic disease since 1980s (78, 79). Hard ticks are principal
vectors, whereas small rodents are known as their natural verte-
brate reservoir. A wide variety of signs including rash, joint pains,
fever, enlarged lymph nodes, and some neurological signs may
www.frontiersin.org October 2014 | Volume 2 | Article 144 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cantas and Suer Bacterial zoonoses: “One Health” concept
develop. The trend of house buildings in woodlots where humans
share the same ecology with reservoirs and vectors was found
to be correlated with the increased frequency of such diseases in
humans (79).
Bartonella spp. is transferred to humans via fleas, lice, and sand
flies (80). However, recent studies have shown the importance
of tick exposure in human bartonellosis (81). As previously men-
tioned elsewhere in this article, bartonellosis are usually associated
with cat-scratch diseases. Lately, researchers have revealed that Bar-
tonella spp. can be transmitted via cat fleas without any scratches
to humans (82). Symptoms include fever, enlarged lymph nodes
(after 1–3 weeks), and a papule at the inoculation site.
Etiological agent of tularemia, F. tularensis, is a rare disease
in Europe (83). Bacteria are usually transferred by slaughtering
(hunters are at a higher risk), eating of infected hares, respiration
of dust, or drinking of contaminated water (84). The prevalence
of F. tularensis was found to be 1–5% from dog ticks in North
America (85). Clinical symptoms depend on how the organ-
ism is acquired: erythematous papule at inoculation side within
48 h, pneumonia (the most serious form), endotoxemia, which
gives continuous fever, acute pharyngotonsillitis, mucopurulent
conjunctivitis (rarest form) (86).
Among many others, brucellosis, which is not an emerging dis-
ease, has a significant impact on the endemic Southern European
countries with sporadic outbreaks. Fortunately, the impact on
humans has not increased since 2000 (87). However, the cross bor-
der tracing of some Brucella strains isolated in Germany revealed
concordance with sheep isolates originating from Eastern Anato-
lian, Turkey. It is a characteristic example for the global spread of
such diseases, in that case most probably by Turkish immigrants
living in Germany (88).
Plague, caused by Yersinia pestis, is the most important re-
emergent bacterial wild rodent borne disease. The current case
reports of plague are primarily limited to Africa. However, it is a
great potential public health hazard for Europe due to increased
traveler mobility or a potential bioterrorist attack (89).
DISCUSSION AND CONCLUSION
Bacterial zoonoses have a major impact on global public health.
Both emerging and re-emerging bacterial zoonoses have gained
increasing national and international attention in recent years. The
closer contact with companion animals and rapid socioeconomic
changes in food production system has increased the number of
animal-borne bacterial zoonoses.
Animal bite injuries in daily human-animal contact are not
surprising, especially for the school-aged children. Most of these
wounds are medicated by patients as first aid and not registered in
health systems. In more developed countries, most of the victims
with moderate to severe bite injuries will seek professional med-
ical treatment. Regardless, all bites should be treated as serious,
especially if the skin is broken. Prompt diagnostic and treat-
ment can prevent wound complications. The possibility to form
biofilms by previously mentioned wound microorganisms is quite
high, may cause severe tissue damage and protect the bacteria
from innate-immune response and antimicrobials. The most of
the commercial topical agents and wound dressings are ineffec-
tive against the biofilm matrix. Surgical repair (for example, CO2
surgical laser techniques, Leon Cantas, personal research notes
2014), which is usually used to obtain a better cosmetic result
might be needed to remove biofilm formed bite infections. This
mechanical debridement is essential in the eradication of a wound
biofilm. Antimicrobials may be more effective in the treatment of
the wound after debridement in the prevention of biofilm refor-
mation. Despite the use of currently optimal culturing methods,
approximately 7% of infected wounds yield no bacterial growth.
In such cases, some other fastidious pathogens, i.e., Chlamydia
spp., Mycoplasma spp., and even viruses should be investigated.
New advanced molecular diagnostic techniques are needed. Pre-
vention strategies for animal bites include close supervision of
child–animal interactions, stronger animal control laws, better
reporting of animal bites, and public education for better own-
ership of pets. Regular nail trimming, routine oral examinations
under annual health checks and comprehensive dental treatments
of the companion animals (i.e., routine removal of the teeth tar-
tar and plaques) by veterinarians will reduce the bacterial mass
exposure to humans in case of direct contacts or animal bites.
It is important to realize that enteropathogenic zoonoses may be
contracted from both clinically sick and apparently healthy com-
panion animals. Feeding of pets with raw food diets is a potential
source of Salmonella, Campylobacter, and other important bac-
terial zoonoses; however, some recalls of commercial pet food
diets have also occurred as a result of contamination with those
microorganisms. Pig ear dog treats, in particular, have been impli-
cated as an important source of Salmonella infection for dogs,
which can also serve as a source of infection to humans.
Nevertheless, it can be said that easy-to-use personal hygiene
rules should be applied by companion animal owners. Thorough
hand washing with soap after handling of a companion animal
and before eating or drinking, avoiding mouth-to-mouth contact,
avoiding aerosolization of dusty fecal matter will help to prevent
transmission of the zoonotic disease to humans. The animals with
diarrhea should be isolated immediately and veterinary advice
should be sought. The household should be cleaned with agents
and kept as clean as possible.
On the other hand, the prevalence of antimicrobial resistance
in small animal pathogens is increasing globally due to overuse of
broad spectrum antibiotics by veterinarians. There is an imme-
diate need for worldwide smarter use of antimicrobials that have
some positive effect on the recovery of animals from life threaten-
ing diseases. National veterinary antimicrobial treatment guide-
lines should be established by the local authorities according to
the updated routine surveillance results.
Chronic diarrhea, dermatitis, ear and eye infections of pets
caused by microbes demand longer durations of antimicrobial
remedies at home. More frequent use of advanced laboratory
tests, such as; feed/insect/mould allergy tests and differential diag-
nosis of the other relevant auto-immune disorders may help
to investigate the main underlying cause of the such reactions
which can be managed in various alternative treatment methods
(i.e., hypoallergenic diets) rather than antibiotics solely. Herein,
pet specific auto-immune vaccines against allergens and auto-
Lactobacillales (Auto-Lac, Leon Cantas, personal research notes,
2011–2014) as dietary supplements can also be more frequently
administered within the preventative veterinary practice measures.
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Owners should be encouraged to insure their family animals
to afford such costly veterinary services contradictory to the
cheaper and sometimes life-long medical (i.e., antibiotic) treat-
ment demanding options. Veterinarians should also spear more
time to educate the pet owners under consultations to handle
infected-antimicrobial treated animals with precaution due to
irreversible consequences of the antimicrobial resistance devel-
opment and its spread in households. Proper hand washing and
use of gloves are strictly recommended while handling antimi-
crobial in veterinary clinics. Veterinarians should prescribe broad
spectrum and synthetic antimicrobials preferably after culturing
with extreme precautions (i.e., dosage, dosing intervals and length
of the treatment). Reduced antibiotic use will hinder the develop-
ment of antibiotic resistance in animal microbiota which might
cause zoonotic infections in humans (50, 52).
Food-borne zoonoses are an important public health concern
worldwide and every year a large number of people affected by dis-
eases due to contaminated animal originated food consumption.
Food hygiene education of the consumers is an important compe-
tent of food-borne diseases prevention. However, main prevention
of food-borne zoonoses must begin at the farm level with in the
concept of “One Health.” Herein, control of the production stress
especially in intensive livestock industry, with the development of
better animal health management routines (i.e., routine vaccina-
tions, immune stimulants: pre-, probiotic feed additives) and the
increased animal welfare programs, will contribute eventually to
an optimal production of animal health. Increased antimicrobial
resistance among emerging and re-emerging farm-borne bacterial
pathogens in crowded settings (i.e., poultry, pig farms) is a growing
problem. Restrictive antimicrobial choice with better animal wel-
fare managements are needed to control the spread of antibiotic
resistance elements.
In the EU, the use of avoparcin was banned in 1997 and the use
of spiramycin, tylosin, and virginiamycin for growth promotion
were banned in 1998. All other growth promoters used in feeding
of food producing animals were banned from January 1, 2006 after
a few national bans the years ahead3. In the U.S., politicians are still
discussing to introduce a similar ban (S-742, 109th U.S. Congress
(Preservation of Antibiotics for Medical Treatment Act). Despite
the ban on the use of all antibiotics as growth promoters in the
EU and a ban on the use of quinolones as growth promoters in
the poultry feed in the US medical, important antibiotics are still
routinely fed to livestock prophylactically to increase profits and to
ward-off potential bacterial infections in the stressed and crowded
livestock and aquaculture environments in some parts of the world
(50, 90, 91). Because stress lowers the immune system function
in animals, antibiotics are seen as especially useful in intensive
animal confinements (92). The non-therapeutic use of antibiotics
involves low-level exposure in feed over long periods – an ideal way
to enrich resistant bacterial population (93, 94). Moreover, antibi-
otic resistance has been detected in different aquatic environments
(95). Fish pathogenic bacteria often produce devastating infections
in fish farms where dense populations of fish are intensively reared.
Bacterial infections in fish are regularly treated with antibiotics in
medicated feed. So far, most of the fish pathogenic bacteria with a
3http://europa.eu
history in diseased fish farms have developed drug resistance (96).
Modern fish farming relies increasingly on vaccination procedures
and improved management to avoid infections (97). For example,
the Norwegian aquaculture industry has produced over one mil-
lion tons farmed fish4 by using improved vaccines, management
techniques, and only 649 kg of antimicrobials in 2011 (98).
Vector-borne and zoonotic bacterial pathogens are a major
source of emerging diseases, and since the time of Hippocrates,
weather and climate are linked to the incidence of such infectious
diseases. Complexity of epidemiology and adoptive capacity of
microorganisms and the arthropods make the vector-borne dis-
ease almost impossible to eradicate. Insect repellants, routine tick
checks after outdoor activity in risk regions, prompt-proper tick
removal, use of long sleeves and trousers (light-colored), and rou-
tine insecticide treatment of pets are recommended as general
preventative measures (99). Herein, Lyme disease, tick-borne ill-
ness, is vastly underestimated over past decades and clearly the
urgent prevention is needed. Besides individual awareness of such
vector-borne diseases, better national surveillance and reporting
programs will contribute to improved the disease control strate-
gies. Clinicians have an important role in the effective management
of vector-borne zoonotic diseases, with enhanced differential diag-
nostic skills based on clinical symptoms and rapid molecular
identification techniques (100–103). Most of the time, the clin-
icians are on the first line of detection of these epidemics due
to large group of patients with novel sets of similar symptoms.
Increased medical networking via online databases offer a broad
overview to followers with regard to changes in temporal pat-
terns of illness in real time, which helps faster detection of new
epidemics (104).
Identification and control of emergent zoonotic bacterial dis-
eases require a “One Health” approach, which demands combined
efforts of physicians, veterinarians, epidemiologists, public health
workers, and urban planners. Collaborative international routine
surveillance strategies, prompt – reliable agent identification tech-
niques, and optimization of the treatment regiments will ensure
the prevention and management of such infections.
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